Skip to content

Clinical trials

Cardiotoxicity trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20151
20171
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Heinrich-Heine University, Duesseldorf1
Myocardial Solutions1
PD Dr. Andrew Chan1
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)1
Technische Universität Dresden1
University Hospital Muenster1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity6
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Esophageal Neoplasms1
Heart Failure1
Multiple Sclerosis1
Neoplasms1
Neuroblastoma1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1
Sarcoma1

Trials

Showing 76 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.